Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
ALPINE IMMUNE SCIENCES, INC. (NVLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/03/2022 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 9.9% stake in ALPINE IMMUNE SCIENCES, INC.
09/30/2022 SC 13G GREAT POINT PARTNERS LLC reports a 7.8% stake in ALPINE IMMUNE SCIENCES, INC.
04/22/2022 SC 13G Lynx1 Capital Management LP reports a 5.1% stake in Alpine Immune Sciences, Inc.
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 16.1% stake in Alpine Immune Sciences, Inc.
12/23/2020 SC 13G Avidity Partners Management LP reports a 5.6% stake in Alpine Immune Sciences, Inc.
08/06/2020 SC 13G Omega Fund IV, L.P. reports a 6.9% stake in § 240.13d-2 Alpine Immune Sciences, Inc.
01/28/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy